Skip to main content
HR 5568 115th Congress House Health Advanced technology and technological innovations Congressional oversight Drug safety, medical device, and laboratory regulation Educational facilities and institutions Government information and archives Health programs administration and funding Health technology, devices, supplies Higher education Manufacturing Prescription drugs Product development and innovation Research administration and funding Research and development

National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018

Introduced: April 18, 2018 Introduced by: Pallone, Frank Democratic · New Jersey See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 18, 2018
Introduced in House
Apr 18, 2018
Referred to the House Committee on Energy and Commerce.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018

This bill authorizes the Food and Drug Administration to partner with institutions of higher education to designate them as National Centers of Excellence in Continuous Pharmaceutical Manufacturing for the purpose of studying and recommending improvements to the process of continuous manufacturing of medications. (Currently, most medications are manufactured in batches.)

What's happening now April 18, 2018

Referred to the House Committee on Energy and Commerce.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Republican 1
R
Guthrie, Brett
Kentucky · Apr 18, 2018
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5568: National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018. 115th Congress. Open America. https://openamerica.io/bill/115-HR-5568/
MLA
"H.R. 5568: National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-5568/.
Bluebook (legal)
H.R. 5568, 115th Cong. (2026), https://openamerica.io/bill/115-HR-5568/.
Markdown link
[H.R. 5568: National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018](https://openamerica.io/bill/115-HR-5568/)
Report a problem